Loading...
XSHE300501
Market cap323mUSD
Jan 03, Last price  
12.52CNY
1D
-3.40%
1Q
-10.57%
Jan 2017
-65.87%
IPO
1.76%
Name

Shanghai Haishun New Pharmaceutical Packaging Co Ltd

Chart & Performance

D1W1MN
XSHE:300501 chart
P/E
27.67
P/S
2.32
EPS
0.45
Div Yield, %
0.26%
Shrs. gr., 5y
5.25%
Rev. gr., 5y
15.02%
Revenues
1.02b
+0.82%
149,003,104210,237,307277,366,830289,849,722293,978,431301,275,888375,617,177507,195,935621,030,370713,784,961856,857,7951,012,601,2351,020,872,006
Net income
85m
-16.61%
19,791,06734,058,14244,466,12454,224,08958,767,41464,603,52165,811,23266,165,09666,976,219102,903,824104,645,765102,461,49185,441,741
CFO
101m
-26.55%
026,495,96528,403,10462,805,42553,274,73033,462,32055,089,70327,489,66795,878,08277,485,971139,639,384136,957,656100,596,590
Dividend
May 28, 20240.15 CNY/sh
Earnings
May 08, 2025

Profile

Shanghai Haishun New Pharmaceutical Packaging Co.,Ltd. manufactures, sells, and exports primarily pharmaceutical packaging films in China and internationally. It offers cold-forming aluminum foils, PVC/Aclar high barrier thermoformable films, tropical blister foils, lidding foils for PTP blisters, AL/PE suppository laminates, child-resistant packaging, complex laminated flexible films, AL/PE strip packs, and PVC/PVDC transparent films under the HiPack brand name. The company is headquartered in Shanghai, China.
URL
https://www.hysum.com/
IPO date
Feb 04, 2016
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,020,872
0.82%
1,012,601
18.18%
Cost of revenue
894,792
845,920
Unusual Expense (Income)
NOPBT
126,080
166,682
NOPBT Margin
12.35%
16.46%
Operating Taxes
14,642
13,071
Tax Rate
11.61%
7.84%
NOPAT
111,439
153,611
Net income
85,442
-16.61%
102,461
-2.09%
Dividends
(6,245)
(23,058)
Dividend yield
0.22%
0.83%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
133,936
165,054
Long-term debt
566,790
125,874
Deferred revenue
40,255
38,723
Other long-term liabilities
2
162
Net debt
(415,033)
(269,488)
Cash flow
Cash from operating activities
100,597
136,958
CAPEX
(298,823)
Cash from investing activities
(326,984)
Cash from financing activities
595,263
FCF
(292,912)
10,721
Balance
Cash
766,711
351,664
Long term investments
349,048
208,752
Excess cash
1,064,715
509,786
Stockholders' equity
1,117,354
874,027
Invested Capital
1,598,853
1,479,594
ROIC
7.24%
11.49%
ROCE
4.73%
8.38%
EV
Common stock shares outstanding
194,186
193,532
Price
14.43
0.00%
14.43
-26.75%
Market cap
2,802,101
0.34%
2,792,660
-13.30%
EV
2,478,888
2,606,104
EBITDA
180,917
212,595
EV/EBITDA
13.70
12.26
Interest
11,481
5,323
Interest/NOPBT
9.11%
3.19%